Effectiveness of <scp>JAK</scp> Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study
JAKis had a slightly better effect on pain outcomes at 3 and 12 months compared with TNFis, with significantly greater differences in patients previously treated with at least two bDMARDs. The effect of JAKis on pain reduction was at least similar to that of non-TNFi bDMARDs.
Authors
- Katerina Chatzidionysiou (ORCID: https://orcid.org/0000-0002-2669-1247)
- Daniela Di Giuseppe (ORCID: https://orcid.org/0000-0003-3817-8288)
- Johan Askling (ORCID: https://orcid.org/0000-0003-0433-0616)
- Tor Olofsson (ORCID: https://orcid.org/0000-0002-9919-4487)
- Alf Kastbom (ORCID: https://orcid.org/0000-0001-7187-1477)
- Thomas Frisell (ORCID: https://orcid.org/0000-0002-5735-9626)
- Stefan Bergman (ORCID: https://orcid.org/0000-0002-6294-538X)
- Carl Turesson (ORCID: https://orcid.org/0000-0002-3805-2290)
- Helena Forsblad‐d’Elia (ORCID: https://orcid.org/0000-0001-7871-5303)
- Hannah Bower (ORCID: https://orcid.org/0000-0002-2046-3833)
- Anna Eberhard (ORCID: https://orcid.org/0000-0001-9408-4150)
Institutions
- Linköping University (SE)
- Karolinska University Hospital (SE)
- Malmö University (SE)
- Lund University (SE)
- Karolinska Institutet (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1002/art.43014
- Citations
- 9
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 4.23